Skip to main content

Table 1 Clinical characteristics, demographic information before the start of the trial (baseline) according to the groups

From: Effects of calcium supplementation on changes in the IL2, IL4, IL6, IL10 axes and oxidative stress in pregnant women at risk for pre-eclampsia

Variable

Calcium group 500 mg/day

Calcium group

1,500 mg/day

Placebo Group

P-value

Mean (SD)

Mean (SD)

Mean (SD)

Age (years)

30.2 (5.1)

30.4 (5.1)

28.6 (4.7)

0.327

Education (years of study)

12.4 (5.5)

12.4 (4.6)

13.9 (5.3)

0.427

Gestational age (weeks)

26.9 (4.0)

26.3 (4.7)

28.2 (5.0)

0.299

Initial weight (Kg)

94.2 (17.3)

86.5 (16.3)

87.7 (17.9)

0.227

Initial BMI (Kg/m2)

35.7 (5.9)

32.6 (7.1)

32.7 (6.2)

0.161

Dietary calcium (g)

531.5 (315.7)

731.5 (477.0)

569.7 (310.1)

0.135

Initial SBP (mmHg)

131.6 (13.8)

131.5 (11.2)

127.8 (12.6)

0.416

Initial DBP (mmHg)

84.2 (9.3)

83.8 (13.2)

81.3 (8.9)

0.531

Triglyceride, mg/dl

224.9 (18.1)

211.2 (15.1)

137.8 (8.9)

0.075

Cholesterol, mg/dl

201.0 (6.9)

235.8 (8.0)

227.1 (6.9)

0.195

LDL-c, mg/dl

101.7 (5.7)

123.8 (6.9)

116.3 (5.8)

0.063

HDL-c, mg/dl

62.8 (3.4)

65.6 (3.5)

76.6 (3.7)

0.393

Hs-CRP, mg/dl

14.3 (1.8)

10.5 (1.3)

3.3 (0.3)

0.268

Ionized calcium, mg/dl

9.1 (0.2)

9.1 (0.2)

9.4 (0.2)

0.832

  1. ANOVA – independent samples / # Chi-square. SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, LDL-c low-density lipoprotein cholesterol, HDL-c high-density lipoprotein cholesterol, hs-CRP ultrasensitive C-reactive protein